Stock Earnings

Question 1

What are Phathom Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Phathom Pharmaceuticals Inc has a total asset of $378, Net loss of $-334

Question 2

What are the key financial ratios for PHAT?

Accepted Answer

Phathom Pharmaceuticals Inc's Current ratio is 0.59, has a Net margin is -607.27, sales per share of $0.87.

Question 3

How is Phathom Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Phathom Pharmaceuticals Inc largest revenue segment is Vonoprazan, at a revenue of 55,252,000 in the most earnings release.For geography, United States is the primary market for Phathom Pharmaceuticals Inc, at a revenue of 55,252,000.

Question 4

Is Phathom Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Phathom Pharmaceuticals Inc has a net loss of $-334

Question 5

Does Phathom Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Phathom Pharmaceuticals Inc has liability of 631

Question 6

How many outstanding shares for Phathom Pharmaceuticals Inc?

Accepted Answer

Phathom Pharmaceuticals Inc has a total outstanding shares of 68.51

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	147	55	0	0	0	0
Revenue Growth (YoY)	465%	--	--	--	--	--
Cost of Revenue	18	7	0	--	--	--
Gross Profit	128	47	0	--	--	--
Selling, General & Admin	308	290	117	101	62	27
Research & Development	33	34	49	71	72	98
Operating Expenses	341	324	167	172	135	125
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-274	-334	-201	-197	-143	-129
Income Tax Expense	--	--	--	--	--	--
Net Income	-274	-334	-201	-197	-143	-129
Net Income Growth	-19%	66%	2%	38%	11%	-49%
Shares Outstanding (Diluted)	73.39	63.17	51.28	39.12	30.51	33.23
Shares Change (YoY)	14%	23%	31%	28%	-8%	34%
EPS (Diluted)	-3.74	-5.29	-3.93	-5.05	-4.72	-3.88
EPS Growth	-28.99%	35%	-22%	7%	22%	-62%
Free Cash Flow	-225	-266	-139	-147	-148	-70
Free Cash Flow Per Share	-3.06	-4.21	-2.71	-3.75	-4.85	-2.1
Gross Margin	87.07%	85.45%	0%	--	--	--
Operating Margin	-144.89%	-503.63%	0%	0%	0%	0%
Profit Margin	-186.39%	-607.27%	0%	0%	0%	0%
Free Cash Flow Margin	-153.06%	-483.63%	0%	0%	0%	0%
EBITDA	-213	-277	-167	-172	-135	-125
EBITDA Margin	-144.89%	-503.63%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-213	-277	-167	-172	-135	-125
EBIT Margin	-144.89%	-503.63%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Phathom Pharmaceuticals Inc (PHAT) Price

PHAT Stock Price Chart

PHAT Income

Follow-Up Questions